Market Research Blog

Injectable drug delivery is the mode of introduction of a drug directly into the bloodstream of a patient. Drugs are directly injected into the bloodstream of patients, owing to which they need to be sterile. Sterile injectable drugs are usually available in liquid form. Sterile injectable drugs are usually permit to transport directly into blood stream sometimes. The manufacturing of sterile injectable drugs is a complex process and recurs high initial investment and operating cost.

Major factor that is increasing the demand for sterile injectable is increasing number of cancer cases. According to the World Cancer Research Fund International (WCRFI), around 14.1 million cancer cases were accounted worldwide in 2012. As per the WCRFI, till 2035, the number is expected to reach 24 million. Small molecule monoclonal antibodies are used for cancer treatment therapy. Cancer therapies are the import engine of the growth of the sterile oncology injectable market.

Focus of the Manufacturers on Technologies, Materials and Robust Manufacturing Process

The supply of drugs is short in the U.S., with some shortage continuing for multiple years. The majority of these drugs are generic sterile injectable products. Companies are focusing on increase in supply of sterile oncology injectable. Manufactures are now focusing on superior technology and procurement of higher grade raw materials. Contract manufacturing organization can help to address drug shortage problem in North America and Europe. They adopt new technologies and rapidly transfer in sterile injectable manufacturing processes.

Dynamics of the Sterile Oncology Injectable Market

The global sterile oncology injectable market is projected witness significant growth over the forecast period due to rising prevalence of cancer globally. Increase in investment by drug manufactures in the development of sterile oncology injectable, short time frame for approval of new drug in cancer treatment are some of the key factor boosting demand for sterile oncology injectable market globally. Rapid FDA approvals of sterile oncology injectable along with shortened approval times for drug development in cancer care is helping manufacturers to accelerate drug supplies.

These factors are eventually boosting the growth of the global sterile oncology injectable market. However, stringent rules and regulations in manufacture of sterile oncology injectable and high quality and care required in manufacturing, challenges in storage, packaging and distribution of oncological sterile injectable are likely to hamper the growth of sterile oncology injectable market. Also, sterile drugs require complex equipment for manufacturing.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-6604

Market Expansion Due to Agreements and Partnerships

Sterile oncology injectable manufacturers are focusing on partnership and geographical expansion in different countries to establish facilities in various regions. Pfizer has expanded its oncology portfolio with acquisition of Hospira. Hospira has a broad sterile injectable product line, which includes acute care and oncology injectable. Baxter also acquired India-based injectable firm Claris Injectable Limited and expanded its portfolio in anti-infective, analgesics and critical care and oncology injectable.

Regional Market Outlook

North America will continue to dominate the global market due to the availability of advanced technologies and more number of clinical trial, surge in demand for innovative medical technology in the U.S. According to the National Institute of Cancer in 2016, around 1,685,210 new cancer cases are likely to be diagnosed in the U.S. Europe is expected to hold second large market share in global sterile oncology injectable market due to growing prevalence of chronic diseases. Competition from low-cost pharmaceutical manufacturing countries such as India and China has led to discontinuation of many products.

Asia Pacific is expected to exhibit attractive market share owing to increase in health awareness and demand for advanced medical technology in oncology treatment and increasing investments on low-cost pharmaceutical manufacturing.

Competition Outlook

Examples of some of the key players identified in the global sterile oncology injectable market are Eli Lilly & Company, Biocon Ltd, Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceuticals Industries Ltd, and Pfizer Inc., among others. Sterile oncology injectable are used for cancer treatment and therapies.

Recent M&A activities have fueled the growth prospect for sterile oncology injectable. Recent deal of US$ 17 Billion between Pfizer & Hospira provides platform for growth for Pfizer’s Global Established Pharmaceutical (GEP) business. Hospira’s generic sterile injectable products, including acute care and oncology injectable have provided boost to Pfizer’s sterile injectable offerings in oncology market. However, preference of large molecules offers a global opportunity to its manufacturers, as these are the common molecules recently used globally for oncology application.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-6604

Key Data Points Covered in Report

The report covers exhaustive analysis on:

• Sterile Oncology Injectable Market by molecule type, distribution channel, indication and region
• Regional level market analysis of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding China & Japan, China, Japan, Middle East & Africa by molecule type, distribution channel, indication segments and country
• Sterile Oncology Injectable Market Dynamics & Opportunity Assessment
• Historical Actual Market Size, 2013 – 2017
• Sterile Oncology Injectable Market Size & Forecast 2018-2028
• Sterile Oncology Injectable Market Current Trends/Issues/Challenges
• Competition & Companies involved

Research Methodology

The market sizing of sterile oncology injectable will be done by adoption data triangulation approach. Demand side approach will be followed to assess the actual market size of sterile oncology injectable. Secondary research will be performed at the initial phase to identify the Age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information will be eventually analyzed during the entire research project, which helps build a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate. Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analyzed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-6604

Market Segmentation

By Molecule Type

• Small Molecule
• Large Molecule

By Product type

• Chemotherapy
• Monoclonal Antibodies
• Cytokines
• Peptides Hormones

By Indication

• Ovarian Cancer
• Breast Cancer
• Lung Cancer
• Pancreatic Cancer
• Other

By Distribution Channel

• Hospitals
• Retail Pharmacies
• Online Pharmacies

By Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific Excluding China & Japan
• China
• Japan
• Middle East & Africa

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The senior in-home care services industry is benefiting from a growing number of aging baby boomers. People now-a days have longer life expectancy due to the advancements in medicine and technology, and thus increasing number of seniors are looking to age in their homes and maintain independence for as long as possible.

Senior in-home care service providers deliver customized solutions according to patient’s budget and needs. Senior in-home care services are provided by licensed healthcare professionals or caregivers and may provide daily assistance to make sure that activities of daily living are met.

Senior in-home care is an alternative to facility care for senior patients who are terminally ill, are recovering from major surgeries or need support for safety at home to prevent unnecessary hospitalization etc. Number of qualified caregivers are increasing over time which is expected to push the adoption of senior in-home care services market over the forecast period of 2017–2027.

The Popularity of in-home health services in the U.S. has increased since in 1995 when more people died of chronic diseases than of acute diseases. Ever increasing need for home-care due to prevalence of chronic diseases itself shows the importance of senior in-home care services.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5525

Senior In-Home Care Services Market: Drivers and Restraints

Rapidly aging population and desire for living independent aging are primary factors driving growth of senior in-home care services market. Average age of the population has risen in last decade and elder people are typically willing to stay at home and maintain existing lifestyle.

According to The Home Care Assistance–one of the providers of senior in-home care services in the U.S. – there will be over 1 Mn centenarians in North America by 2015. Moreover, in-home care services are also getting reimbursement which is expected to enhance the adoption of senior in-home care services in near-term.

Government of many countries are also encouraging people to take in-home care services to minimize healthcare spending. On top of that, rising prevalence of Alzheimer’s disease, Parkinson’s disease and other chronic diseases such as cancer is expected to drive the global market for senior in-home care services over the forecast period of 2017–2027.

However, in developing and underdeveloped countries, in-home care is costlier that the facility care and thus people are not ready to adopt senior in-home care services, which is the major challenge to growth of the global market.

Senior In-Home Care Services Market: Segmentation

Tentatively, global senior in-home care services market has been segmented on the basis of service type, and geography

Based on service type, global senior in-home care services market is segmented as below:

• Wellness and Medical Services
• Companionship Care and Homemaking Services
• Nursing Care Services
• Alzheimer’s and Dementia Care Services
• Hospice Care and Rehabilitation Services
• Physical and Occupational Therapy Services
• Others

Senior In-Home Care Services Market: Overview

The market for senior in-home care services is highly fragmented with no single dominant player in the world as majority of players are operation in particular region or country only. In-home care services are also known as companion aides, personal care aides, certified home health aides or nursing aides. In-home care services to seniors also enrich their lives with physical, metal, social and emotional activities.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5525

Senior In-Home Care Services Market: Regional Outlook

Geographically, global senior in-home care services market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America clearly dominates the global senior in-home care services market due to high rate of reimbursement for medical as well as non-medical services.

Europe is expected to be the second largest market due to rising number aging of baby boomers requiring care at home. Asia Pacific senior in-home care services market is still in initial phase of development and expected to witness fastest growth in the nearest future due to acceptance for personal dignity of the elder loved ones by the families

Senior In-Home Care Services Market: Key Players

Some of the players identified in global senior in-home care services market include Sunny Days In-Home Care, Inc., Right at Home, LLC., Comfort Keepers Inc., Home Instead Inc. Home Helpers Home Care Services, SYNERGY HomeCare, Home Care Assistance etc. among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-5525

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

An allergy is a heightened sensitivity of immune system.  Allergy occurs when a foreign substance which is harmless in nature reacts with immune system. These foreign substances are called allergens. Some of the allergens that affect the immune system are dust mite, animal dander, cockroach, pollens and mold. Dust mite, animal dander and mold can cause indoor allergy problems.

Allergy can be of various types such as eye allergy, Rhinitis, asthma, skin allergy, etc. According to the World Allergy Organization, approximately 30-40% of the world population was affected by allergic condition in 2011. Severe allergy can be life threatening in some patients as allergy severity reduces the function of organs such as allergic asthma causes the poor lungs function.

Allergy Treatment Market: Drivers and Restraints

Globally, increasing patient population with various type of allergies, changing life style and environment pollution is increasing, which drives the global allergy treatment market. Increasing number of patients with various allergies such as skin allergy, eye allergy, Rhinitis, asthma, etc., changes in dietary habits, rising demand for advanced therapy for allergy treatment, increasing research and development activities, government initiative, are some of the factors that drive the growth of the global allergy treatment market. However, high cost of immunotherapy for allergy treatment and side effects from immunotherapy act as a restraint in the global allergy treatment market.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1342

Allergy Treatment Market: Overview

Allergic diseases occur due to hypersensitivity of the immune system towards environment that usually causes minute problems in most individuals. These allergic diseases includes food allergy, allergic asthma, hay fever, atopic dermatitis and anaphylaxis. Symptoms for these allergic diseases are runny nose, an itchy rash, shortness of breath, red eyes, swelling and some more.

Such allergies are treated by avoiding known allergens, immunotherapy and by the use of medications such as antihistamines and steroids. In industrialized countries, allergic diseases are more common as compared to the countries that are more agricultural or traditional and it is noticed that there is a lower rate of allergic disease in rural populations versus urban populations.

Allergy Treatment Market: Region- wise Outlook

Depending on geographic regions, global allergy treatment market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan and Middle East & Africa. North America followed by Europedominates the global allergy treatment market due to increasing number of patients with various type of allergies including respiratory allergy, skin allergy, eye allergy, etc.

growing environmental pollution, developed healthcare infrastructure and growing demand for immunotherapy for treatment of allergies in these region. Asia-Pacific is the fastest emerging market for global allergy treatment due to growing allergic patient population, increasing awareness about advanced immunotherapy for treatment of allergies available in the market, developing healthcare infrastructure and rising government spending in healthcare industry in this region.

Allergy Treatment Market: Key Players

Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and Vicks.

Currently, the companies which operate in allergy treatment, are entering into mergers and acquisition with other companies to expand its allergy treatment business. For instance, in June 2015, Allergy Therapeutics acquired Alerpharma S.A, a Spanish company develops and now offers allergy immunotherapy products and services to expand its allergy immunotherapy business.

In addition, In November 2015, Pfizer Inc., a multinational pharmaceutical corporation entered into a merger with Allergan PLC, a pharmaceutical company to capture more market share in the drug industry.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-1342

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-1342

Allergy Treatment Market: Segmentation

Global allergy treatment market is further segmented into following types:

• By Allergy Type
• Eye allergy
• Rhinitis
• Asthma
• Skin allergy
• Other allergy
• By Allergy Treatment Type
• Anti-allergy medicine
• Antihistamines
• Corticosteroids
• Decongestants
• Mast cell stabilizers
• Other medicines (Leukotriene, Calcineurin, Cromoglicate, Anti-IgE)
• Immunotherapy

Global allergy treatment market is further segmented into End User

• Hospital
• Clinics
• Medical store
• Home use
• Others

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Each year traumatic brain injuries (TBI) contribute a substantial number of cases worldwide. TBI can be defined as an injury to the brain resulting from externally inflicted trauma resulting in damage to the brain cells and blood vessels. The signs and symptoms of TBI may appear soon after the head trauma or may sometimes take several days to weeks to appear.

TBI can be categorized as mild, moderate and severe brain injury. In case of a mild injury a patient experiences a brief concussion and in rare situations may lead to lasting functional brain changes. However, the risk of developing severe and permanent brain damage increases with the extent and severity of the traumatic brain injury and the level of unconsciousness.

Depending up on the location of the injury,  TBI can lead to dementia along with memory, lack of concentration, problems related with speech and eating, lack of coordination and walking problems are often associated with moderate to severe brain injuries. As estimated by Center for Diseases Control and Prevention (CDC) every day 138 people in the U.S. die from TBI.

According to the CDC 2010 estimates in the U.S. approximately 2.5 million emergency department visits and hospitalization were associated with TBI cases (either alone or in combination with other injuries).  Falls are leading cause of hospitalization in patients with TBI followed by accidents including motor, vehicle traffic injuries.

Mild traumatic brain injuries do not require treatment other than over the counter pain relievers and the patient with mild traumatic injury need not to be monitored in hospital.  However for treatment of severe TBI several medications indicated includes several diuretics, anti- seizure drugs, comma inducing drugs etc.

However, in case of severe TBI surgery and rehabilitation is required. The traumatic brain injuries treatment market is expected to witness higher growth over the forecast period owing to introduction of several new therapies. Increasing number of manufacturers are developing new medications for the treatment of TBI and large number of clinical trials are conducted in order to better understand the etiology of the condition.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2678

Traumatic Brain Injuries Treatment Market: Drivers & Restraints

Extensive R&D by U.S. Food and Drug Administration (FDA) scientists in order to study various biomarkers of brain imaging, bio fluid and physical indicators such as eye tracking and electroencephalography holds immense potential as diagnostic techniques for detection of TBI. This is expected to change the treatment pattern of TBI in patients with severe brain injuries.

Apart from this a large number of clinical trials are conducted worldwide in order to develop effective therapies for TBI have proven to be opportunistic for the market growth of TBI treatment in the near future.

Furthermore rising incidence of falls cases along with accidental cases are expected to be the leading accelerating factors for market growth of TBI treatment market globally. The expected entry of some molecular targeted therapies such as BHR-100, a progesterone drug being developed by BHR Pharma, LLC,  rhuEpo, a recombinant human erythropoietin are expected to brace the TBI treatment market growth over the forecast period.

However, factors such as low societal awareness, delayed diagnosis and low government funding in TBI treatment research are expected to hamper the TBI treatment market growth in the future.

Traumatic Brain Injuries Treatment Market: Overview

The traumatic brain injury treatment market is expected to increase at an alarming rate among children’s and adults over the forecast period. In children’s, few outcomes of TBI may not be encountered at an initial stage of but can emerge in later developmental stages of his/her life which may lead to chronic behavior problems and  social isolation.

Better understanding of the injury mechanisms and its effect on sub-populations is required in order to manage the TBI. Growing number of falling cases and accidental cases worldwide are expected to drive revenue growth of TBI treatment in the near future.

Traumatic Brain Injuries Treatment Market: Region-wise Outlook

On the basis of region presence, traumatic brain injuries treatment market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. The incidence of TBI is higher in regions such as Asia Pacific, North America and Western Europe.

TBI is the major cause of mortality accounting for 30% of all death related injuries in the U.S. Presence of several pipeline therapies in treatment of TBI is expected to be the biggest driver in global TBI treatment market. Cognosci, a privately held U.S. start-up is developing a novel therapeutic compound, COG1410, for the treatment of TBI which is expected to launch in the coming years.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2678

Traumatic Brain Injuries Treatment Market: Key Players

Some of the key market players in the traumatic brain injuries treatment market are, Zimmer Biomet, Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc, TEVA Pharmaceutical Industries Ltd., Ischemic,  Grace Laboratories LLC. Several key players developing therapeutics for TBI treatment include, Cognosci, Medicortex, Amarantus BioScience Holdings, Aldagen, NeuroScience Pharmaceuticals and Targacept.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2678

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Diabetes has evolved as one of the primary healthcare epidemic characterized by high sugar levels and principle cause of mortality worldwide.  In 2014, World Health Organization (WHO) estimated 8.5% of adults living with diabetes.  A diabetic person cannot either synthesize enough insulin (type 1 diabetes) or either does not make enough insulin or cannot effectively use the insulin produced by the body (type 2 diabetes).

Another type of diabetes that occur in women during her pregnancy is gestational diabetes. However, gestational diabetes is usually resolved after delivery but can precede towards type 2 diabetes later in a women’s life.  Most of the continuous glucose monitoring devices are invasive and involves use of needles leading to increased chance of infection. Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose.

Certain evidences of hyperglycemia between measurements are however not recorded thus resulting in false or no representation of the blood glucose pattern.  Noninvasive monitoring of glucose levels eliminates the need of painful pricking with increased risk of infection, and amount of damage caused to the finger tissue.

Therefore, non-invasive continuous glucose monitoring devices are being widely investigated and studied over the past few years for their ability to monitor glucose continuously under highly controlled (e.g. in-clinic) conditions. Various techniques that involves measurement of blood glucose levels non-invasively includes, Near Infrared Spectroscopy (NIRS), Mid -Infrared Spectroscopy (Mid-IRS), Raman Spectroscopy, Photo-acoustic Spectroscopy (PA), Optical Coherence Tomography (OCT) and many more.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Drivers & Restraints

Rising prevalence of diabetes globally is expected to result in greater use of noninvasive blood glucose monitoring devices among the prevalent population. Owing to the several disadvantages imposed by the use of invasive blood glucose monitors and growing need to develop noninvasive glucose monitoring diagnostic techniques, the market for non- invasive blood glucose monitoring devices is expected to rise at a greater pace during the forecast period.

For instance, in June 2015, researchers in U.K. developed blood glucose device that utilizes low-powered lasers in order to measure the blood glucose levels on the skin surface. Also a bench-top version of the system is currently in clinical trials studies which might land in the market over the next few years.

This includes, a finger-touch device similar to a computer mouse and a wearable version for continuous blood glucose monitoring. In addition, increasing efforts by several startup manufacturers, for example, Prediktor Medical- a Norway based manufacturer is developing a wearable device for estimation of blood glucose levels based on the combination of several principles determining the noninvasive glucose monitoring including, advanced multivariate analysis and dynamic models for insulin or glucose interaction.

The device is expected to be in the form of a watch or bracelet communicating with the mobile phone or a tablet for data presentation.  This would enable patient’s monitor their glucose levels continuously without the need for an implant. Currently available blood glucose measuring devices lacks specificity and sensitivity due to the substantial physical and chemical interference.

Non-invasive glucose monitoring devices use multivariate regression analyses converting optical signal to glucose concentration. Hence the device should be designed in such a way that it leads to accurate detection of blood glucose levels imperative for optimum therapy and disease management.

Non- Invasive Blood Glucose Monitoring Devices Market: Overview

Rising prevalence of diabetes worldwide imposes significant economic consequences on the individual’s life. Currently, there are 350 million people worldwide estimated to live with diabetes. Thus continuous monitoring of blood glucose levels is essential in order to manage the ever increasing prevalent population living with diabetes currently.

For this reason manufacturers are focusing on developing diagnostic techniques that are highly reliable and monitors individual’s blood glucose levels with greater accuracy with the capability to improve glycemic control and patient wellbeing.

By integration of sensing elements, electronics along with a reliable power source in a single unit, noninvasive blood glucose monitors are offering immense opportunity for all the device manufacturers along with patients and various healthcare providers across the world. Accelerated regulatory approvals of blood glucose monitors is one of the another important factor leading to increased revenues of noninvasive blood glucose devices over the forecast period.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Region-wise Outlook

On the basis of region presence, Non- Invasive Blood Glucose Monitoring Devices market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa.

Growing number of diabetic population in U.S. is the leading factor contributing towards higher adoption of noninvasive blood glucose monitoring systems. Center of Diseases Control and Prevention estimated 29.1 million of U.S. population with diabetes in the U.S. The data also estimated adult population with diabetes are at 50% higher risk of death.

Furthermore, growing need of continuous non-invasive method of blood glucose diagnosis among patients is expected to create higher demand for noninvasive blood glucose monitoring systems worldwide. The incidence of diabetes is higher in regions such as Asia Pacific, North America and Western Europe. Presence of several pipeline blood glucose monitoring systems and their expected launch is expected to drive the market for noninvasive blood glucose devices over the forecast period.

Non- Invasive Blood Glucose Monitoring Devices Market: Key Players

Some of the key market players in the non- invasive blood glucose monitoring devices market are, Abbott, Animas Technologies, Bayer Healthcare, Cercacor, Pendragon Medical, OrSense, and Bayer Healthcare.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2613

Non- Invasive Blood Glucose Monitoring Devices Market: Segmentation

Non- invasive blood glucose monitoring devices marketis segmented by technology, modality end user and geography:

By Technology

• MIR/NIR (Mid/Near Infrared Spectroscopy)
• Raman Spectroscopy
• Occlusion Spectroscopy
• Optical Coherence Tomography
• Thermal Emission Spectroscopy
• Photoacoustic Spectroscopy
• Impedance/Dielectric Spectroscopy
• Electromagnetic
• Polarimetry
• Fluorescence

By Modality

• Wearable Blood Glucose Monitoring Systems
• Non-wearable /Table top Blood Glucose Monitoring Systems

By End User

• Hospitals
• Home Care Settings
• Clinics
• December 2022
• REP-GB-2613
• Upcoming
• Healthcare

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global pharmaceutical filtration market is expected to enjoy a valuation of US$ 17.8 Bn by the end of 2022 and further expand at a CAGR of 8.7% to reach a valuation of ~US$ 41.0 Bn by 2032. According to the recent study, membrane filters segment by product is leading the market with a share of about 33.3% in 2021.

Active pharmaceutical ingredients are a key component of the pharmaceutical industry in the 21^st century. Filters are essential in a number of cases during the course of API creation and are necessary in bioscience laboratory applications as well. An increased production of large biologics and molecules, nano fibre technological advancements, generic market growth, and regulatory guidelines for cleanroom pharmaceutical production are the main factors driving the pharmaceutical filtration market. Additional funds diverted towards R&D expenditure by major biopharmaceutical organizations also boost the profile of the pharmaceutical filtration market

• Manufacturing has the major portion of the revenue share in the pharmaceutical filtration market by operation in 2017 and is likely to remain so throughout the duration of the forecast period. The manufacturing segment is expected to cross a value of more than US$ 9.3 billion by end 2022 making it imperative for companies to be present in this operation segment of the pharmaceutical filtration market. The pilot scale segment follows at a considerable distance but cannot be overlooked entirely in favour of manufacturing. The pilot scale filtration segment has strong scope in North America as the continent represents a little over a third of the pharmaceutical filtration market and is estimated to retain this share going forward

• The cell separation segment comprises slightly above a sixth of the pharmaceutical filtration market by application and is predicted to lose popularity in the future. Nonetheless, the North America cell separation market alone is on track to push past a billion dollars by end 2022 and companies are advised to take this into account while devising their business strategies. The water purification segment has a similar revenue share to the cell separation segment in the pharmaceutical filtration market by application. After North America, the water purification segment is particularly prominent in Europe
• In terms of technology, microfiltration is quite popular as it contributes nearly half the revenue share in the pharmaceutical filtration market in the year 2017. Furthermore, microfiltration is anticipated to witness a high CAGR of more than 5.5% for the period 2017-2022 ensuring that all key stakeholders have ample opportunity in this lucrative technology. Ultrafiltration is not as prominent as microfiltration in the pharmaceutical filtration market but is gaining traction recently. Ultrafiltration technology has the greatest scope in both North America and Europe as these two continents are projected to cross a billion dollars in terms of value by end 2022
• North America is the largest region in the pharmaceutical filtration market and is poised to grow to more than US$ 6 billion by end 2022
• The report has profiled a few of the companies in the pharmaceutical filtration market. These include The Marmon Group LLC, Sartorius Stedim Biotech, Meissner Filtration Products, Parker Hannifin Corporation, Pall Corporation, Merck KGaA, GE Healthcare Inc., Eaton Corporation Plc., Amazon Filters Ltd., and 3M Companies.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5028

Key Segments:

Pharmaceutical Filtration Market Taxonomy

Region

• North America
• Latin America
• Europe
• Japan
• APEJ
• MEA

Product Type

• Membrane Filters
• Prefilters and Depth Media Filters
• Single-use Systems
• Cartridge & Capsule Filters
• Filter Holders
• Filtration Accessories
• Other Products

Scale of Operation

• Manufacturing Scale
• Pilot Scale
• R&D Scale
• Application
• Final Product Processing
• Raw Material Filtration
• Cell Separation
• Water Purification
• Air Purification

Technology

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Other techniques

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-5028

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global animal healthcare market was estimated to be valued at US$ 42.3 Billion in 2021. The market is likely to grow at a CAGR of 4.3% through 2027, reaching US$ 54.5 Billion by 2027.

Along with animal health care, the rapid expansion of the animal feed additive market has also been witnessed with an expected compound annual growth rate (CAGR) of 4.6% through 2027, surpassing a valuation of around US$ 25.3 Bn, whereas, the production of animal segment, by animal type, is expected to grow at 4.7% CAGR, reaching around US$ 35 Bn by 2027.

Improved animal health is drastically becoming a top priority for people and governments across the world since they have a vital contribution to maintaining the balance of the ecosystem. Billions of dollars are being spent on vaccines, pharmaceuticals, and feed additives every year in order to protect animals from a wide range of diseases.

Key Takeaways

• Surging demand for animal pharmaceuticals and vaccines will therefore continue to boost the growth of the animal healthcare market during the forecast period.
• A huge variety of pharmaceuticals are being used to treat production and companion animals such as antibiotics, antiparasitics, anti-inflammatories, analgesics, and fertility drugs. Increasing awareness about animal care is set to spur growth in the animal healthcare market.
• The rapid surge in animal healthcare product sales like pharmaceuticals is acting as a catalyst for the growth of the animal healthcare market and the trend is likely to continue in the future.
• The increasing consumption of meat and dairy products, the rising prevalence of foodborne and zoonotic diseases, growing trend of pet adoption across the globe are some of the primary factors fueling demand in the animal healthcare market during the forecast period.
• The account of rising pet adoption rates growing awareness about maintaining the proper health of animals, and surging demand for animal pharmaceuticals for enhancing the immunity system of animals over the last few decades have led to an increase in spending on animals significantly.
• North America and Europe are projected to dominate the animal healthcare market, accounting for more than 60% of the market share and North America alone will command a market value of US$ 18.2 billion.

Competitive Landscape

Bayer AG, Cargill, Inc., Eli Lilly and Company, Boehringer Ingelheim GmbH, Ceva Sante Animale, Zoetis Inc., Merc & Co., Inc., Virbac S.A., and SeQuent Scientific Ltd. Etc. are some of the key companies profiled in the full version of the report.

Leading market players operating in the global animal healthcare market are constantly increasing in research and development for introducing new products at low costs. Besides this, they are adopting growth strategies such as partnerships, acquisitions, price reduction, and moving towards online platforms to expand tehri global footprint.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-431

More Insights into the Animal Healthcare Market

The global animal healthcare market falls under the seven major regional segments such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA).

North America is leading the global animal healthcare market, accounting for the maximum market share and the revenue is expected to reach US$ 18,186.4 Mn by 2027 end. The Western Europe market is expected to account for the second largest market value share during the forecast period.

With the rapid expansion of the pet care market and surging demand for animal pharmaceuticals, North America and Europe will collectively constitute more than 60% of the market share over the forecast period.

Asia Pacific region is expected to grow at a phenomenal pace during the forecast period owing to the rising adoption of pets, expansion of the animal feed additives market, and penetration of new veterinary healthcare market entrants in countries like India and China.

On the basis of animal type, the global animal healthcare market has been segmented into production animals and companion animals.

The production animals segment is projected to grow at the fastest CAGR over the forecast period, reaching around US$ 35,041.9 Mn by 2027 end. The companion animals segment, on the other hand, is projected to grow at a CAGR of 3.6% over the forecast period.

Increased focus on protecting both production and companion animals from lethal diseases will continue to push the animal healthcare product sales during the forecast period.

Market Segmentation

Based on Product Type:

• Feed Additives
• Pharmaceuticals
• Vaccines

Based on Animal Type:

• Production Animals
• Companion Animals

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-431

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

The global orthopaedic bone cement and casting materials market is also likely to witness a few trends in the near future. Growing research and development activities in the field of orthopaedics and increasing use of casting materials to treat orthopaedic injuries are expected to increase in the next few years, impacting the global market for orthopaedic bone cement and casting materials significantly.

In a recent global market study, the analysts of Future Market Insights examined the various factors impacting revenue growth of the global orthopaedic bone cement and casting materials market. An increasing prevalence of orthopaedic disorders and patient preference towards quality treatment for a better lifestyle are primarily responsible for fuelling market demand for orthopaedic bone cement and casting materials. The global orthopaedic bone cement and casting materials market is expected to enjoy a valuation of US$ 2.7 Bn in 2022. Sales in the market are projected to expand at a CAGR of 6.3% over the forecast period (2022-2032). Demand in the market is expected to surge by 2.1x, surpassing a valuation of ~US$ 5.1 Bn by 2032.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-4825

Future Market Insights analysis reveals the various factors that are likely to boost the growth in adoption of orthopaedic bone cement and casting materials. A growing number of people suffering from bone diseases such as osteoporosis, an increasing number of sports injuries and accidents leading to fractures of the bone, and the availability of advanced treatment options for severe back pain are some of the factors likely to drive the market towards high revenue growth in the coming decade.

Global Orthopaedic Bone Cement and Casting Materials Market: Regional Analysis & Forecast

Future Market Insights has tracked the performance of the global orthopaedic bone cement and casting materials market across the key geographies of North America, Latin America, Western Europe, Eastern Europe, Japan, APEJ, and MEA. Unsurprisingly, North America is the dominant regional market with estimated revenues in excess of US$ 1,400 Mn by the end of 2027, witnessing a CAGR of 5.1%. The APEJ orthopaedic bone cement and casting materials market is estimated to be valued at almost US$ 940 Mn by the end of 2027, recording an impressive CAGR of 9.7% – the highest among all the regional markets. The Western Europe regional market is slated to register a CAGR of 7.1% during 2017 – 2027.

Global Orthopaedic Bone Cement and Casting Materials Market: Segmental Forecasts

Forecast by Product Type:

The global orthopaedic bone cement and casting materials market is segmented on the basis of product type into Bone Cement and Casting Materials. The Bone Cement segment is expected to be the most lucrative product type segment with an attractiveness index of 1.1 and a CAGR of 6.9% in terms of value.

Forecast by Application:

The global orthopaedic bone cement and casting materials market is segmented on the basis of application into Joint Arthroplasty, Trauma Cases, Sports Injury, Spine Surgeries, and Others. Joint Arthroplasty is the most lucrative segment by application and also the largest, estimated to reach a market valuation of US$ 1,458.6 Mn by the end of 2027, registering a CAGR of 7.3%.

Forecast by End User: 

The global orthopaedic bone cement and casting materials market is segmented on the basis of end user into Hospitals, Ambulatory Surgical Centres, and Orthopaedic Clinics. Hospitals is the largest end user segment, estimated to reach a market valuation of just under US$ 2000 Mn and witness a growth rate of 7.0% between 2017 and 2027.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-4825

Global Orthopaedic Bone Cement and Casting Materials Market: Competitive Landscape

• DJO Global, Inc.,
• Heraeus Holding,
• Zimmer Biomet,
• BeneCare Medical,
• BSN medical,
• Stryker,
• 3M Health Care Ltd.,
• DePuy Companies (Sub. Johnson & Johnson Services, Inc.),
• Smith & Nephew Plc,
• Exactech, Inc.,
• Medtronic, Inc.,
• Braun Melsungen AG,
• Cook Medical,
• SOMATEX® Medical Technologies GmbH,
• TEKNIMED,
• T-Tape Company B.V.,
• Lohmann & Rauscher GmbH & Co. KG,
• MIKA MEDICAL,
• Össur,
• Innovation Rehab LTD.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-4825

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs